Loteprednol Etabonate
35 NDCs across 10 manufacturers|25 Generic,10 Brand
Loteprednol Etabonate is used to treat allergic conjunctivitis, bacterial conjunctivitis, viral conjunctivitis, edema, inflammation and iritis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 9, 1998, and the first generic was approved Apr 17, 2019. FDA's Orange Book lists 15 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $79 million on Loteprednol Etabonate across 339,000 claims for 187,000 beneficiaries.
Loteprednol Etabonate is available as 35 NDCs from 10 manufacturers (25 generic, 10 brand), with NADAC prices from $10.47 to $103.11 per ML — the most expensive product costs about 9.8× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
35
25G / 10B
Manufacturers
10
competing in market
Price Spread
$10.47 – $103.11
per ML, 29 of 35 NDCs
7d Activity
avg -0.1% WoW · of 35 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Bausch & Lomb Incorporated manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Corticosteroid class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
10 manufacturers producing LOTEPREDNOL ETABONATE(2 pricing outliers)
Frequently Asked Questions
What is Loteprednol Etabonate used to treat?
Loteprednol Etabonate is used to treat allergic conjunctivitis, bacterial conjunctivitis, viral conjunctivitis, edema, inflammation and iritis, per the National Library of Medicine's MED-RT classification.
When did Loteprednol Etabonate become available as a generic?
FDA approved the first generic Loteprednol Etabonate (ANDA) on Apr 17, 2019. The Orange Book currently lists 15 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Loteprednol Etabonate?
In 2024, Medicare Part D spent $79 million on Loteprednol Etabonate across 339,000 claims for 187,000 beneficiaries.
How many Loteprednol Etabonate products are on the market?
The Loteprednol Etabonate drug market contains 35 NDCs from 10 manufacturers — 25 generic and 10 brand products.
What is the price range for Loteprednol Etabonate?
NADAC reference prices for Loteprednol Etabonate range from $10.4737 to $103.1107 per ML — the most expensive product costs about 9.8× the cheapest. 6 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Loteprednol Etabonate cheaper than brand?
The average generic NADAC for Loteprednol Etabonate is $18.0799 per ML, versus $63.0220 for brand-labeled products — brand versions average about 3.5× the generic price.
Which manufacturers make Loteprednol Etabonate?
10 manufacturers list Loteprednol Etabonate in NADAC. Ranked by number of NDCs, the largest are Bausch & Lomb Incorporated (9), Bausch & Lomb Americas Inc. (5), ARMAS PHARMACEUTICALS INC. (3), Sun Pharmaceutical Industries Inc. (3), Padagis US LLC (3).
How has the price of Loteprednol Etabonate changed recently?
Over the past 7 days, 5 Loteprednol Etabonate NDCs rose and 22 fell, with a market-wide average change of -0.1%.